Usefulness of hypertriglyceridemia in predicting myocardial infarction late after coronary artery bypass operation

American Journal of Cardiology

Volumn 79, Issue 10, 1997, Pages 1350-1354

  Voors, Adriaan A ^b   Van Brussel, Ben L ^b   Kelder, Johannes C ^b   Plokker, H W Thijs ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 0030909752     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00138-0     Document Type: Article

References (25)

1. Campeau L, Enjalbert M, Lesperance J, Bourassa MG, Kwiterovich P Jr, Wacholder S, Sniderman A. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med 1984;311:1329-1332.
2. Allard C, Goulet C, Grondin CM, Lesperance J, Bourassa MG. Patency of aortocoronary vein grafts and serum triglycerides. Three year follow-up study. Am J Cardiol 1974;33:679-680.
3. Daida H, Yokoi H, Miyano H, Mokuno H, Satoh H, Kottke TE, Hosoda Y, Yamaguchi H. Relation of saphenous vein graft obstruction to serum cholesterol levels. J Am Coll Cardiol 1995;25:193-197.
4. Palac RT, Meadows WR, Hwang MH, Loeb HS, Pifarre R, Gunnar RM. Risk factors related to progressive narrowing in aortocoronary vein grafts studied 1 and 5 years after surgery. Circulation 1982;66(suppl 1):I-40-1-4.
5. Hoffmann RG, Blumlein SL, Anderson AJ, Barboriak JJ, Walker JA, Rimm AA. The probability of surviving coronary bypass surgery. Five-year results from 1,718 patients. JAMA 1980;243:1341-1344.
6. Lindén T, Bondjers G, Karlsson T, Wiklund O. Serum triglycerides and HDL cholesterol - major predictors of long-term survival after coronary surgery. Eur Heart J 1994;15:747-752.
7. Cataldo G, Braga M, Pirotta N, Lavezzari M, Rovelli F, Marubini E. Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA). Circulation 1993;88(suppl II):II-93-II-8.
8. Fox MH, Gruchow HW, Barboriak JJ, Anderson AJ, Hoffmann RG, Flemma RJ, King JF. Risk factors among patients undergoing repeat aorta-coronary bypass procedures. J Thorac Cardiovasc Surg 1987;93:56-61.
9. Cosgrove DM, Loop FD, Lytle BW, Gill CC, Golding LA, Gibson C, Stewart RW, Taylor PC, Goormastic M. Predictors of reoperation after myocardial revascularization. J Thorac Cardiovasc Surg 1986;92:811-821.
10. Stewart JW, Goormastic M, Healy B, Lytle BW, Hoogwerf BJ, Cressman MD, Sheldon WC, Loop FD. Clinical outcome ten years after coronary bypass: effects of cholesterol and triglycerides in 4913 patients. J Am Coll Cardiol 1988;11:7A.
11. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoportein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996;77:1179-1184.
12. Myers WO, Schaff HV, Gersh BJ, Fisher LD, Kosinski AS, Mock MB, Holmes DR, Ryan TJ, Kaiser GC. Improved survival of surgically treated patients with triple vessel coronary artery disease and severe angina pectoris. A report from the Coronary Artery Surgery Study (CASS) registry. J Thorac Cardiovasc Surg 1989;97:487-495.
13. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-202.
14. Averna M, Seip RL, Mankowitz K, Schonfeld G, Postprandial lipemia in subjects with hypobetalipoproteinemia and a single intestinal allele for apoB-48. J Lipid Res 1993;34:1957-1967.
15. Barboriak JJ, Rimm AA, Anderson AJ, Tristani FE, Walker JA, Flemma RJ. Heart disease indicators in patients with aortocoronary bypass operation. Cardiology 1976;61:153-161.
16. Billington T, Janus ED, Sinclair HC. Lipids and lipoproteins in patients undergoing coronary-artery surgery. Med J Aust 1989;150:302-304,306.
17. Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 1990; 81:470-476.
18. Yli Mayry S, Huikuri HV. Clinical and angiographic prediction of myocardial infarction and recurrence of severe angina during a five-year follow-up after coronary artery bypass grafting. Am J Cardiol 1993; 72:1371-1375.
19. Shepherd J, Krauss RM. Pathophysiology of triglyceride-rich particles. A. Metabolism of triglyceride-rich particles. Am J Cardiol 1991;68:5A-7A.
20. Loop FD, Lytle BW, Cosgrove DM, Golding LA, Taylor PC, Stewart RW. Free (aorta-coronary) internal mammary artery graft. Late results. J Thorac Cardiovasc Surg 1986;92:827-831.
21. Sergeant P, Lesaffre E, Flameng W, Suy R, Blackstone E. The return of clinically evident ischemia after coronary artery bypass grafting. Eur J Cardiothorac Surg 1991;5:447-457.
22. Cameron AA, Davis KB, Green GE, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts-effects on survival over a 15-year period. N Engl J Med 1996;334:216-219.
23. van Sterkenburg SM, Ernst SM, Brutel de la Riviere A, Defauw JA, Hamerlynck RP, Knaepen PJ, van Swieten HA, Vermeulen FE. Triple sequential grafts using the internal mammary artery. An angiographic and short-term follow-up study. J Thorac Cardiovasc Surg 1992;104:60-65.
24. Grondin CM, Campeau L, Thornton JC, Engle JC, Cross FS, Schreiber H. Coronary artery bypass grafting with saphenous vein. Circulation 1989;79 (suppl I):I-24-I-9.
25. Bourassa MG. Fate of venous grafts: the past, the present and the future. J Am Coll Cardiol 1991;17:1081-1083.